Literature DB >> 11868786

Characteristics of hepatocellular carcinoma in Japan.

Kendo Kiyosawa1, Eiji Tanaka.   

Abstract

Malignant neoplasias are the leading cause of death in Japan at present, of which hepatocellular carcinoma (HCC) ranks the third most frequent in men and the fourth most frequent in women. Annual deaths due to HCC are rising sharply and amounted to 33,000 in 1999. Chronic hepatitis C is the most frequent etiology of HCC in Japan and accounts for nearly 90% of cases. The recent rapid increase of HCC in Japan is a long-term sequel of hepatitis C virus infection that affected many individuals in the past, and manifests itself currently as HCC. Infection with the hepatitis C virus has prevailed since the end of World War II for reasons inherent in the socioeconomic background in Japan.

Entities:  

Mesh:

Year:  2002        PMID: 11868786     DOI: 10.1159/000048269

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  20 in total

Review 1.  Management of hepatocellular carcinoma in Japan.

Authors:  Kiwamu Okita
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

2.  Clinical characteristics of hepatocellular carcinoma in elderly patients.

Authors:  Takuya Honda; Hisamitsu Miyaaki; Tatsuki Ichikawa; Naota Taura; Satoshi Miuma; Hidetaka Shibata; Hajime Isomoto; Fuminao Takeshima; Kazuhiko Nakao
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

3.  Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.

Authors:  Hai-Gang Li; De-Rong Xie; Xi-Ming Shen; Hong-Hao Li; Hong Zeng; Yun-Jie Zeng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

4.  Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma.

Authors:  Naota Taura; Tatsuki Ichikawa; Hisamitsu Miyaaki; Hiroshi Yatsuhashi; Hiromi Ishibashi; Kazuhiko Nakao
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

5.  HCV-related proteins activate Kupffer cells isolated from human liver tissues.

Authors:  Naohiro Hosomura; Hiroshi Kono; Masato Tsuchiya; Kenichi Ishii; Masahito Ogiku; Masanori Matsuda; Hideki Fujii
Journal:  Dig Dis Sci       Date:  2010-09-17       Impact factor: 3.199

6.  Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.

Authors:  Takashi Iwata; Noritoshi Nishiyama; Koshi Nagano; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Takuma Tsukioka; Shoji Hanada; Kiyotoshi Inoue; Shoji Kubo; Shigekazu Takemura; Shigefumi Suehiro
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.

Authors:  Norifumi Harimoto; Tomoharu Yoshizumi; Yukiko Fujimoto; Takashi Motomura; Youhei Mano; Takeo Toshima; Shinji Itoh; Noboru Harada; Toru Ikegami; Hideaki Uchiyama; Yuji Soejima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

8.  Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.

Authors:  Chao-Yang Lou; Ying-Ming Feng; Ai-Rong Qian; Yu Li; Hao Tang; Peng Shang; Zhi-Nan Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

9.  Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C.

Authors:  Naoki Fujita; Yoshiyuki Takei
Journal:  J Gastroenterol       Date:  2007-11       Impact factor: 7.527

10.  Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma.

Authors:  M Abu-Hilal; J N Primrose; A Casaril; M J W McPhail; N W Pearce; N Nicoli
Journal:  J Gastrointest Surg       Date:  2008-07-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.